The U.S. filed its first charges in a generic drug price-fixing probe on Wednesday, according to a report.
The Justice Department charged two former Heritage Pharmaceuticals executives in Philadelphia on Wednesday, Bloomberg reported. Former CEO Jeffrey Glazer and former President Jason Malek were accused of colluding with other generic pharmaceutical companies to fix prices, following a two year investigation, the report said.
The Justice Department charged two former Heritage Pharmaceuticals executives in Philadelphia on Wednesday, Bloomberg reported. Former CEO Jeffrey Glazer and former President Jason Malek were accused of colluding with other generic pharmaceutical companies to fix prices, following a two year investigation, the report said.
